Cutler Group LP Evolus, Inc. Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$5.22 - $11.78 $17,748 - $40,052	-3,400 Reduced 96.65%	118 $1,000
Q2 2021 Jul 19, 2021	BUY	$8.42 - $13.96 $2,879 - $4,774	342 Added 10.77%	3,518 $44,000
Q1 2021 Apr 26, 2021	SELL	$3.2 - $16.51 $73,488 - $379,152	-22,965 Reduced 87.85%	3,176 $41,000
Q4 2020 Jan 21, 2021	SELL	$2.92 - $4.84 $139,961 - $231,990	-47,932 Reduced 64.71%	26,141 $87,000
Q3 2020 Oct 27, 2020	BUY	$3.03 - $5.48 $223,835 - $404,824	73,873 Added 36936.5%	74,073 $289,000
Q1 2020 May 07, 2020	SELL	$3.53 - $12.21 $15,885 - $54,945	-4,500 Reduced 95.74%	200 $0
Q4 2019 Feb 06, 2020	BUY	$11.58 - $17.37 $37,056 - $55,584	3,200 Added 213.33%	4,700 $57,000
Q3 2019 Oct 28, 2019	SELL	$13.91 - $19.87 $30,602 - $43,714	-2,200 Reduced 59.46%	1,500 $23,000
Q2 2019 Aug 09, 2019	SELL	$13.19 - $28.36 $35,613 - $76,572	-2,700 Reduced 42.19%	3,700 $54,000
Q1 2019 May 10, 2019	BUY	$12.43 - $28.91 $77,066 - $179,242	6,200 Added 3100.0%	6,400 $144,000
Q4 2018 Feb 05, 2019	BUY	$10.57 - $19.29 $2,114 - $3,858	200 New	200 $2,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.